Prostate Cancer Genetic Risk Evaluation and Screening Study
Prostate Cancer Genetic Risk Evaluation and Screening Study
Recruiting · NCT05129605 · Registry updated 2024-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prostate Cancer Genetic Risk Evaluation and Screening Study | Colorectal Neoplasms, Hereditary Nonpolyposis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Genital Diseases, Lynch syndrome, Male Urogenital Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, disease susceptibility, hereditary disease, hereditary neoplastic syndrome, inherited disease susceptibility, intestinal disorder, male reproductive organ cancer, male reproductive system disorder, metabolic disease, mismatch repair cancer syndrome 1, neoplasm, prostate cancer, prostate disorder | Recruiting | Not stated | 2024-10-09 | NCT05129605 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |